Mitglied werden

Zoetis Inc. (ZTS)

Healthcare • Drug Manufacturers - Specialty & Generic

48
Beobachten
$125,56
Kurs
-0,86%
Veränderung
55,33 Mrd. $
Marktkapitalisierung
-
KGV

Neumann-Score Aktienanalyse

48
von 100 Punkten
Beobachten
Bewertung??/100
Profitabilität??/100
Wachstum??/100

Score-Details freischalten

Werden Sie Mitglied und erhalten Sie Zugang zu allen Analysen.

Mitglied werden

Über Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise ...

CEO
Kristin C. Peck
Mitarbeiter
13.800
Land
US